Introduction: Colchicine is the standard treatment for Familiar Mediterranean Fever (FMF), however about 5% of patients (pts) experience colchicine resistance. There is no standard definition of colchicine resistance. Recently a panel of experts elaborated a new definition based on a Delphi consensus approach. Objectives: We aim to describe main features of the disease and clinical outcome of a cohort of FMF pts with particular interest on the colchicine resistance and tolerability according to the definitions proposed by the recent consensus.
R. Gallizzi, M.B. (2020). Adherence to colchicine treatment and colchicine resistance in a multicentric FMF national cohort. PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL, 18(S2), 59-60.
Adherence to colchicine treatment and colchicine resistance in a multicentric FMF national cohort
M. C. Maggio;
2020-01-01
Abstract
Introduction: Colchicine is the standard treatment for Familiar Mediterranean Fever (FMF), however about 5% of patients (pts) experience colchicine resistance. There is no standard definition of colchicine resistance. Recently a panel of experts elaborated a new definition based on a Delphi consensus approach. Objectives: We aim to describe main features of the disease and clinical outcome of a cohort of FMF pts with particular interest on the colchicine resistance and tolerability according to the definitions proposed by the recent consensus.
| File | Dimensione | Formato | |
|---|---|---|---|
|
PediatricRheumatology_2020_P008.pdf
accesso aperto
Descrizione: PRES2020_P008
Tipologia:
Versione Editoriale
Dimensione
61.21 kB
Formato
Adobe PDF
|
61.21 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
